Herbst was an investigator for a number of trials that targeted - TopicsExpress



          

Herbst was an investigator for a number of trials that targeted surrogate endpoints as part of an effort to speedily assess efficacy, notably the BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) and BATTLE-2 programs for non-small cell lung tumors that used biomarkers from fresh tissue real-time results in less than 2 weeks to treat patients with a number of agents.
Posted on: Thu, 02 Oct 2014 18:21:37 +0000

Trending Topics



Recently Viewed Topics




© 2015